AtaiBeckley (ATAI) Exchange Rate Effect (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Exchange Rate Effect of -$276000.0 for Q1 2026, down 962.5% year-over-year from $32000.0 in Q1 2025, and down 962.5% quarter-over-quarter from $32000.0 in Q1 2025.
Powered by 
Analysis
AtaiBeckley (ATAI) Exchange Rate Effect (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Exchange Rate Effect for 6 years, with the latest figure at -$468000.0 in Q3 2025.
- Quarterly Exchange Rate Effect fell 297.47% year-over-year to -$468000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$107000.0 (down 496.3% YoY) and the FY2024 annual result came in at $362000.0, up 91.53% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$276000.0, down from $32000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $32000.0 in Q1 2025, with the low at -$276000.0 in Q1 2026.
- A 5-year average of -$59052.6 and a median of $66000.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect plunged 3141.18% in 2022, then jumped 212.12% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$17000.0 in 2021, then plunged by 3141.18% to -$551000.0 in 2022, then soared by 61.52% to -$212000.0 in 2023, then surged by 158.02% to $123000.0 in 2024, then tumbled by 480.49% to -$468000.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$468000.0, $206000.0, and $32000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | -468,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -248,000.00 |
| Mar 31, 2026 | -276,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Jun 30, 2025 | 206,000.00 |
| Jun 30, 2025 | 206,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | -64,000.00 |
| Dec 31, 2023 | -212,000.00 |
| Sep 30, 2023 | 318,000.00 |
| Jun 30, 2023 | -76,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | -551,000.00 |
| Sep 30, 2022 | 621,000.00 |
| Jun 30, 2022 | -1.49 Mn |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | -17,000.00 |